Amoxitab 50 mg tablets for dogs and cats
Amoxitab 50 mg tablets for dogs and cats
Authorised
- Amoxicillin trihydrate
Product identification
Medicine name:
Amoxitab 50 mg tablets for dogs and cats
Amoxitab 50 mg Tabletten für Hunde und Katzen
Active substance:
- Amoxicillin trihydrate
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Amoxicillin trihydrate57.50milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Package description:
- (ID9) 90 Tablet: unspecified outer container with 9 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID8) 80 Tablet: unspecified outer container with 8 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID7) 70 Tablet: unspecified outer container with 7 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID6) 60 Tablet: unspecified outer container with 6 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID5) 50 Tablet: unspecified outer container with 5 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID4) 40 Tablet: unspecified outer container with 4 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID3) 30 Tablet: unspecified outer container with 3 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID2) 20 Tablet: unspecified outer container with 2 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID13) 100 Tablet: unspecified outer container with 10 unspecified outer container each with 1 Blister (Aluminium) with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID12) 500 Tablet: unspecified outer container with 50 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID11) 250 Tablet: unspecified outer container with 25 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID10) 100 Tablet: unspecified outer container with 10 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
- (ID1) 10 Tablet: unspecified outer container with 1 Blister (Aluminium) with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
- CP-Pharma Handelsgesellschaft mbH
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 402365.00.00
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0177/001
Concerned member states:
-
Sweden
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: